Light Control of Insulin Release and Blood Glucose Using an Injectable Photoactivated Depot

Mol Pharm. 2016 Nov 7;13(11):3835-3841. doi: 10.1021/acs.molpharmaceut.6b00633. Epub 2016 Oct 15.

Abstract

In this work we demonstrate that blood glucose can be controlled remotely through light stimulated release of insulin from an injected cutaneous depot. Human insulin was tethered to an insoluble but injectable polymer via a linker, which was based on the light cleavable di-methoxy nitrophenyl ethyl (DMNPE) group. This material was injected into the skin of streptozotocin-treated diabetic rats. We observed insulin being released into the bloodstream after a 2 min trans-cutaneous irradiation of this site by a compact LED light source. Control animals treated with the same material, but in which light was blocked from the site, showed no release of insulin into the bloodstream. We also demonstrate that additional pulses of light from the light source result in additional pulses of insulin being absorbed into circulation. A significant reduction in blood glucose was then observed. Together, these results demonstrate the feasibility of using light to allow for the continuously variable control of insulin release. This in turn has the potential to allow for the tight control of blood glucose without the invasiveness of insulin pumps and cannulas.

Keywords: DMNPE; insulin; light controlled drug release; photoactivated depot.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects*
  • Enzyme-Linked Immunosorbent Assay
  • Insulin / chemistry*
  • Insulin / pharmacology
  • Light*
  • Male
  • Photochemistry / methods*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Blood Glucose
  • Insulin